×
About 3,190 results

ALLMedicine™ Actinic Keratosis Center

Research & Reviews  889 results

Hemodynamic changes during conventional and daylight photodynamic therapy of actinic ke...
https://doi.org/10.1080/09546634.2022.2097160
The Journal of Dermatological Treatment; Hartmann J, Keller A et. al.

Jul 2nd, 2022 - Photodynamic therapy (PDT) is an effective treatment for actinic keratosis (AK). However, pain and hypertension are important side effects of conventional PDT (c-PDT). Several studies have demonstrated that daylight PDT (dl-PDT) is less painful wh...

Lichen planus -like keratosis: what do we know about?
https://doi.org/10.1111/ced.15318
Clinical and Experimental Dermatology; Pogorzelska-Antkowiak A

Jul 2nd, 2022 - Lichen planus like keratosis (LPLK) is a benign skin lesions often occurring between the fifth and eighth decades of life. It was first described and diagnosed in 1966. It's a benign lesion presents as a solitary pink, red or grey macule, plaque o...

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis
https://clinicaltrials.gov/ct2/show/NCT05279131

Jun 30th, 2022 - The purpose of the study is to evaluate the safety, tolerability and treatment effect of tirbanibulin ointment 1% when applied to a field of approximately 100 cm^2 on the face or balding scalp.

New insights from non-invasive imaging: from prospection of skin photodamages to traini...
https://doi.org/10.1111/jdv.18197
Journal of the European Academy of Dermatology and Venere... Pellacani G, Argenziano G

Jun 24th, 2022 - The incidence of non-melanoma skin cancer is on the rise and melanoma is among the most common cancers in the United States. Establishing an early diagnosis is essential for improving the prognosis of patients with skin cancer. High-resolution non...

Repurposing of ingenol mebutate for treating human colorectal cancer by targeting S100 ...
https://doi.org/10.1016/j.taap.2022.116134
Toxicology and Applied Pharmacology; Hsieh YY, Cheng YW et. al.

Jun 21st, 2022 - Colorectal cancer (CRC) is the world's second most common cause of cancer-related death. Novel treatments are still urgently needed. S100 calcium-binding protein A4 (S100A4) was demonstrated to be an anticancer therapeutic target. Herein, we found...

see more →

Guidelines  4 results

Management of actinic keratosis at specific body sites in patients at high risk of carc...
https://doi.org/10.1111/jdv.14753
Journal of the European Academy of Dermatology and Venere... Richard MA, Amici JM et. al.

Dec 14th, 2017 - Actinic keratoses (AK) arise on sun-exposed regions of the skin. If left untreated, AK may progress to invasive squamous cell carcinoma (SCC), although the rate of progression is low. A practical treatment algorithm for the treatment of AK in stan...

British Association of Dermatologists' guidelines for the care of patients with actinic...
https://doi.org/10.1111/bjd.15107
The British Journal of Dermatology; de Berker D, McGregor JM et. al.

Jan 18th, 2017 - British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017.|2017|de Berker D,McGregor JM,Mohd Mustapa MF,Exton LS,Hughes BR,|methods,methods,therapeutic use,therapeutic use,diagnosis,prevention & control...

Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - ...
https://doi.org/10.1111/jdv.13180
Journal of the European Academy of Dermatology and Venere... Werner RN, Stockfleth E et. al.

Sep 16th, 2015 - Actinic keratosis (AK) is a frequent health condition attributable to chronic exposure to ultraviolet radiation. Several treatment options are available and evidence based guidelines are missing. The goal of these evidence- and consensus-based gui...

Management of actinic keratosis: a practical report and treatment algorithm from AKTeam...
https://doi.org/10.1111/jdv.12434
Journal of the European Academy of Dermatology and Venere... Dréno B, Amici JM et. al.

Mar 13th, 2014 - Actinic keratoses (AK) are common photo-induced cutaneous lesions that may progress to invasive squamous-cell carcinoma and serve as a risk marker for skin cancer. Although numerous studies present the various therapeutic options for AK, publicati...

see more →

Drugs  8 results see all →

Clinicaltrials.gov  192 results

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis
https://clinicaltrials.gov/ct2/show/NCT05279131

Jun 30th, 2022 - The purpose of the study is to evaluate the safety, tolerability and treatment effect of tirbanibulin ointment 1% when applied to a field of approximately 100 cm^2 on the face or balding scalp.

A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp
https://clinicaltrials.gov/ct2/show/NCT05387525

Jun 9th, 2022 - The purpose of the study is to evaluate the incidence of biopsy confirmed invasive squamous cell carcinoma (SCC) in the selected treatment field (TF) after administration of topical tirbanibulin 10 milligram (mg)/gram (g) ointment or diclofenac so...

Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients With Actinic Keratosis
https://clinicaltrials.gov/ct2/show/NCT05202860

Jun 6th, 2022 - Endeavoring to develop a new therapeutic and preventative strategy for patients with AK, this study aims to investigate the impact of 9-valent HPV vaccination on AK burden and -development over the course of 12 months. Seventy actinic keratosis (A...

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
https://clinicaltrials.gov/ct2/show/NCT05060237

May 26th, 2022 - The aim of the study is to evaluate the safety and tolerability of PDT for treatment of mild to severe actinic keratosis on the face and scalp in the expanded treatment field using 3 tubes of BF-200 ALA 10% gel (Ameluz®) in conjunction with the BF...

Ultrasound in Diagnosing Patients With Skin Lesions
https://clinicaltrials.gov/ct2/show/NCT03914846

May 23rd, 2022 - PRIMARY OBJECTIVES: I. Characterize a wide variety of lesions including but limited to: I a. Malignant lesions: basal cell cancers, squamous cell cancers, Merkel cell cancer, melanoma, etc. I b. Non-malignant lesions: keloids, surgical scars, acti...

see more →

News  178 results

Right arm rash
https://www.mdedge.com/familymedicine/article/251881/dermatology/right-arm-rash
MDedge Family Medicine;

Feb 17th, 2022 - Common skin reactions to treatment with topical 5-FU for actinic keratosis include erythema, ulceration, and burning. In this case, however, the skin disruption opened the door to secondary impetigo.

Pink or red actinic keratoses signal more inflammation
https://www.mdedge.com/dermatology/article/249655/actinic-keratosis/pink-or-red-actinic-keratoses-signal-more-inflammation
Heidi Splete

Dec 8th, 2021 - Pinker or redder actinic keratoses (AKs) indicate greater inflammation, according to a retrospective study that analyzed images and histopathology slides of 49 actinic keratosis lesions. Data suggest that up to 65% of squamous cell carcinomas (SCC.

Ripretinib Demonstrates Impressive Efficacy, Durability in Heavily Pretreated KIT-Mutated Melanoma
https://www.onclive.com/view/ripretinib-demonstrates-impressive-efficacy-durability-in-heavily-pretreated-kit-mutated-melanoma

Dec 4th, 2021 - The efficacy seen with ripretinib (Qinlock) in patients with KIT-mutated melanoma was higher than has been previously reported, according to Filip Janku, MD, PhD. Furthermore, the switch-control tyrosine kinase inhibitor (TKI) has elicited durable...

Phototoxicity Secondary to Home Fireplace Exposure After Photodynamic Therapy for Actinic Keratosis
https://www.mdedge.com/dermatology/article/248260/actinic-keratosis/phototoxicity-secondary-home-fireplace-exposure-after
Lauren A. Hassoun, MD, MAS, Vivian Y. Shi, MD et. al.

Nov 4th, 2021 - To the Editor: Photodynamic therapy (PDT) is a US Food and Drug Administration–approved treatment for actinic keratosis (AK). It also commonly is administered off label for basal cell carcinoma, Bowen disease, photoaging, and acne vulgaris and is.

'Diligent' Dermatology Care Needed in Organ-Transplant Recipients
https://www.medscape.com/viewarticle/961445

Oct 25th, 2021 - NEW YORK (Reuters Health) - Organ transplant recipients (OTRs) face an increased risk for developing multiple skin cancers, "highlighting the importance of diligent dermatology follow-up," researchers write in JAMA Dermatology. There are limited r...

see more →

Patient Education  5 results see all →